1. Introduction
In an important decision of February 8, 2022 the Brussels Dutch Court of Enterprises (hereafter the “Court of Enterprises”) declared null and void a patent on an “apparatus, system…
Artificial Intelligence Systems or Devices cannot be "inventors" under the Australian Patents Act, the Full Federal Court has confirmed. The inventor of a patent must be a natural person. Does there…
The “patent linkage system” is in general a system wherein market approval of generic drugs is linked with the status of the originator drug’s patents, for the purpose of early resolution of patent…
The hurdle for being a co-inventor in a medicine field in Japan might be a little higher than what is expected from precedents. The IP High Court affirmed, in its judgement of 17th March 2021 (2020 …
In two separate judgments, the Full Court has provided much needed clarity on how to identify the pharmaceutical products that can support a valid patent term extension in Australia, as Natalie…
In a complex case concerning blockbuster cinacalcet, Section 15 of the Barcelona Court of Appeals makes findings on the non-obviousness of inventions consisting of the provision of an unexpected…
Meade J reaffirms the UK Courts’ approach to disclosure of confidential information
How far should the Court go to protect a party’s confidential information during disclosure? In a recent decision (…
The Bulgarian Supreme Court of Cassation (SCC) confirmed a second instance court judgment considering, inter alia, the effect of a later exclusive patent license contract having the same subject…
If, in an action for a declaration of invalidity of a patent brought by several plaintiffs, the proceedings against one of the plaintiffs are interrupted pursuant to Section 240 of the Code of Civil…